188 related articles for article (PubMed ID: 9122188)
1. Stat5 is a physiological substrate of the insulin receptor.
Chen J; Sadowski HB; Kohanski RA; Wang LH
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2295-300. PubMed ID: 9122188
[TBL] [Abstract][Full Text] [Related]
2. Dual mechanism of signal transducer and activator of transcription 5 activation by the insulin receptor.
Le MN; Kohanski RA; Wang LH; Sadowski HB
Mol Endocrinol; 2002 Dec; 16(12):2764-79. PubMed ID: 12456798
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
4. Insulin Induction of SOCS-2 and SOCS-3 mRNA expression in C2C12 Skeletal Muscle Cells Is Mediated by Stat5*.
Sadowski CL; Choi TS; Le M; Wheeler TT; Wang LH; Sadowski HB
J Biol Chem; 2001 Jun; 276(23):20703-10. PubMed ID: 11279166
[TBL] [Abstract][Full Text] [Related]
5. A cytosolic protein-tyrosine phosphatase PTP1B specifically dephosphorylates and deactivates prolactin-activated STAT5a and STAT5b.
Aoki N; Matsuda T
J Biol Chem; 2000 Dec; 275(50):39718-26. PubMed ID: 10993888
[TBL] [Abstract][Full Text] [Related]
6. SOCS-3 is an insulin-induced negative regulator of insulin signaling.
Emanuelli B; Peraldi P; Filloux C; Sawka-Verhelle D; Hilton D; Van Obberghen E
J Biol Chem; 2000 May; 275(21):15985-91. PubMed ID: 10821852
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
8. Identification of Stat 5B as a substrate of the insulin receptor.
Sawka-Verhelle D; Filloux C; Tartare-Deckert S; Mothe I; Van Obberghen E
Eur J Biochem; 1997 Dec; 250(2):411-7. PubMed ID: 9428692
[TBL] [Abstract][Full Text] [Related]
9. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
10. The role of GH receptor tyrosine phosphorylation in Stat5 activation.
Hansen JA; Hansen LH; Wang X; Kopchick JJ; Gouilleux F; Groner B; Nielsen JH; Møldrup A; Galsgaard ED; Billestrup N
J Mol Endocrinol; 1997 Jun; 18(3):213-21. PubMed ID: 9195475
[TBL] [Abstract][Full Text] [Related]
11. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.
Liu X; Robinson GW; Gouilleux F; Groner B; Hennighausen L
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8831-5. PubMed ID: 7568026
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
13. In vitro interaction between STAT 5 and JAK 2; dependence upon phosphorylation status of STAT 5 and JAK 2.
Flores-Morales A; Pircher TJ; Silvennoinen O; Gustafsson JA; Sanchez-Gomez M; Norstedt G; Haldosén LA; Wood TJ
Mol Cell Endocrinol; 1998 Mar; 138(1-2):1-10. PubMed ID: 9685210
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) induces the formation of protein complexes involving Stat5, Erk2, Shc and serine phosphorylated proteins.
Dinerstein-Cali H; Ferrag F; Kayser C; Kelly PA; Postel-Vinay M
Mol Cell Endocrinol; 2000 Aug; 166(2):89-99. PubMed ID: 10996427
[TBL] [Abstract][Full Text] [Related]
15. Specific DNA binding and transactivation potential of recombinant, purified Stat5.
Beisenherz-Huss C; Mundt M; Herrala A; Vihko P; Schubert A; Groner B
Mol Cell Endocrinol; 2001 Oct; 183(1-2):101-12. PubMed ID: 11604230
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory cross-talk between STAT5b and liver nuclear factor HNF3beta: impact on the regulation of growth hormone pulse-stimulated, male-specific liver cytochrome P-450 gene expression.
Park SH; Waxman DJ
J Biol Chem; 2001 Nov; 276(46):43031-9. PubMed ID: 11562369
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone stimulates tyrosine phosphorylation of JAK2 and STAT5, but not insulin receptor substrate-1 or SHC proteins in liver and skeletal muscle of normal rats in vivo.
Chow JC; Ling PR; Qu Z; Laviola L; Ciccarone A; Bistrian BR; Smith RJ
Endocrinology; 1996 Jul; 137(7):2880-6. PubMed ID: 8770909
[TBL] [Abstract][Full Text] [Related]
18. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression.
Storz P; Döppler H; Horn-Müller J; Groner B; Pfizenmaier K; Müller G
Anal Biochem; 1999 Dec; 276(1):97-104. PubMed ID: 10585749
[TBL] [Abstract][Full Text] [Related]
19. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
Gouilleux F; Wakao H; Mundt M; Groner B
EMBO J; 1994 Sep; 13(18):4361-9. PubMed ID: 7925280
[TBL] [Abstract][Full Text] [Related]
20. Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity.
Park SH; Yamashita H; Rui H; Waxman DJ
Mol Endocrinol; 2001 Dec; 15(12):2157-71. PubMed ID: 11731617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
